iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionAptus Capital Advisors, LLC
Latest Disclosed Ownership1,929 shares
Latest Disclosed Value $ 325,712
Aptus Capital Advisors, LLC reports 99.06% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 11, 2026 - Aptus Capital Advisors, LLC filed a 13F-HR form disclosing ownership of 1,929 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $325,712 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 204,362 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -99.06% during the quarter. The current value of the position is $252,795 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,929 -202,433 -99.06 326 -99.06 0.0026
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 204,362 202,269 9,664.07 34,490 11,320.53 0.2470
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,093 -175 -7.72 302 5.59 0.0022
2025-08-11 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,268 -688 -23.27 287 -24.34 0.0023
2025-05-13 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,956 920 45.19 378 40.52 0.0039
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,036 1,610 377.93 269 333.87 0.0028
2024-11-05 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 426 114 36.54 62 47.62 0.0009
2024-07-31 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 312 -25 -7.42 43 -8.70 0.0008
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 337 -402 -54.40 46 -54.00 0.0009
2024-02-13 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 739 -5,330 -87.82 100 -86.52 0.0027
2023-11-08 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,069 4,094 207.29 742 196.80 0.0202
2023-08-11 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,975 93 4.94 251 2.88 0.0060
2023-05-09 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,882 -36 -1.88 243 -3.19 0.0065
2023-02-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,918 -1,267 -39.78 252 -32.71 0.0077
2022-11-02 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,185 2,824 782.27 373 788.10 0.0090
2022-07-29 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 361 0 0.00 42 -10.64 0.0011
2022-05-04 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 361 0 0.00 47 -14.55 0.0012
2022-02-02 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 361 0 0.00 55 -5.17 0.0017
2021-10-27 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 361 -35 -8.84 58 -10.77 0.0015
2021-07-27 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 396 0 0.00 65 8.33 0.0019
2021-05-06 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 396 0 0.00 60 1.69 0.0022
2021-02-10 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 396 0 0.00 59 11.32 0.0027
2020-10-19 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 396 -382 -49.10 53 -50.00 0.0028
2020-07-22 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 778 382 96.46 106 152.38 0.0067
2020-05-07 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 396 0 0.00 42 -10.64 0.0036
2020-02-10 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 396 361 1,031.43 47 1,466.67 0.0033
2019-11-14 2019-09-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 35 35 3 0.0002
2019-11-12 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 35 35 3 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.